ES2157862A1 - "nuevas actividades farmacologicas de los extractos del curcuma longa" - Google Patents

"nuevas actividades farmacologicas de los extractos del curcuma longa"

Info

Publication number
ES2157862A1
ES2157862A1 ES200000396A ES200000396A ES2157862A1 ES 2157862 A1 ES2157862 A1 ES 2157862A1 ES 200000396 A ES200000396 A ES 200000396A ES 200000396 A ES200000396 A ES 200000396A ES 2157862 A1 ES2157862 A1 ES 2157862A1
Authority
ES
Spain
Prior art keywords
pharmacological activities
curcuma longa
novel pharmacological
longa extracts
extracts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200000396A
Other languages
English (en)
Other versions
ES2157862B1 (es
Inventor
Almagro Eliseo Quintanilla
Bosca Ana Ramirez
August Bernd
Zapata Jose Pardo
Alperi Joaquin Diaz
Mira Joaquin Pamies
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASAC Cia Biotecnologia e Investigacion SA
Original Assignee
ASAC Cia Biotecnologia e Investigacion SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ASAC Cia Biotecnologia e Investigacion SA filed Critical ASAC Cia Biotecnologia e Investigacion SA
Publication of ES2157862A1 publication Critical patent/ES2157862A1/es
Application granted granted Critical
Publication of ES2157862B1 publication Critical patent/ES2157862B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Abstract

Nuevas actividades farmacológicas de los extractos del Curcuma Longa como agente fotosensibilizante con luz visible en el tratamiento de enfermedades proliferativas, en particular para el tratamiento de la psoriasis. La composición farmacéutica se basa en un extracto hidroalcohólico de Curcuma Longa y un extracto acuoso.
ES200000396A 1999-09-23 2000-02-10 Adicion a la patente principal numero 9902364 con titulo "nuevas actividades farmacologicas de los extractos del curcuma longa" Expired - Fee Related ES2157862B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009902364A ES2154610B1 (es) 1999-09-23 1999-09-23 Nuevas actividades farmacologicas de los extractos de curcuma longa.

Publications (2)

Publication Number Publication Date
ES2157862A1 true ES2157862A1 (es) 2001-08-16
ES2157862B1 ES2157862B1 (es) 2002-03-01

Family

ID=8310389

Family Applications (3)

Application Number Title Priority Date Filing Date
ES200003146A Expired - Fee Related ES2154615B1 (es) 1999-09-23 1999-09-23 Nuevas actividades farmacologicas de los extractos del curcuma longa.
ES009902364A Expired - Fee Related ES2154610B1 (es) 1999-09-23 1999-09-23 Nuevas actividades farmacologicas de los extractos de curcuma longa.
ES200000396A Expired - Fee Related ES2157862B1 (es) 1999-09-23 2000-02-10 Adicion a la patente principal numero 9902364 con titulo "nuevas actividades farmacologicas de los extractos del curcuma longa"

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES200003146A Expired - Fee Related ES2154615B1 (es) 1999-09-23 1999-09-23 Nuevas actividades farmacologicas de los extractos del curcuma longa.
ES009902364A Expired - Fee Related ES2154610B1 (es) 1999-09-23 1999-09-23 Nuevas actividades farmacologicas de los extractos de curcuma longa.

Country Status (9)

Country Link
US (1) US6841177B1 (es)
EP (1) EP1133992B1 (es)
JP (1) JP2003509464A (es)
AT (1) ATE453398T1 (es)
AU (1) AU7525300A (es)
CA (1) CA2351482A1 (es)
DE (1) DE60043609D1 (es)
ES (3) ES2154615B1 (es)
WO (1) WO2001021185A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2317990T3 (es) * 2001-02-09 2009-05-01 New Chapter, Inc. Composicion y metodo para detoxificacion de humo.
US9265808B2 (en) 2004-03-23 2016-02-23 Lifeline Nutraceuticals Corporation Compositions for alleviating inflammation and oxidative stress in a mammal
EP1740196B1 (en) * 2004-03-23 2015-08-26 Lifeline Nutraceuticals Corporation Compositions and method for alleviating inflammation and oxidative stress in a mammal
WO2008010697A1 (es) * 2006-07-19 2008-01-24 Herrera Ramirez Mario Alberto Fármaco a base de curcumina para el tratamiento de infección parasitaria provocada por la giardia lamblia
CN101686725A (zh) 2007-04-03 2010-03-31 刚迦·拉贾·高卡拉贾 消炎和抗氧化协同作用的膳食补充组合物
EP2205255B8 (en) * 2007-10-03 2015-09-30 Sabell Corporation Herbal compositions and methods for treating hepatic disorders
WO2009066303A2 (en) 2007-11-22 2009-05-28 Ganga Raju Gokaraju New synergistic phytochemical composition for the treatment of obesity
WO2009080842A1 (es) * 2007-12-21 2009-07-02 Asac Compañía De Biotecnología E Investigación Sa Composiciones fotoprotectoras
WO2009080850A1 (es) * 2007-12-21 2009-07-02 Asac Compañia De Biotecnologia E Investigacion, S.A. Método para aumentar la eficacia terapéutica de los curcuminoides y análogos.
MY174568A (en) * 2013-12-31 2020-04-27 Sirim Berhad A bioactive composition having natural uv photoprotective properties
CN104888098A (zh) * 2015-05-04 2015-09-09 孙著叶 一种用于关节置换后静脉血栓的中药制剂及制备方法
KR20200029559A (ko) * 2017-07-24 2020-03-18 새미 랩스 리미티드 사용된 강황 - 이의 방법 및 조성물
CN107596252A (zh) * 2017-09-04 2018-01-19 中国科学院化学研究所 姜黄提取物及其制备方法、用途和保健品
JP6709001B1 (ja) * 2019-07-01 2020-06-10 ハウスウェルネスフーズ株式会社 TNF−α又はIL−6産生抑制用組成物
KR102327827B1 (ko) * 2019-11-01 2021-11-18 한국과학기술연구원 강황 추출물을 유효성분으로 포함하고 자외선 처리를 포함하는 건선 개선용 조성물
FR3104947B1 (fr) * 2019-12-18 2022-11-25 Fabre Pierre Dermo Cosmetique Extrait de Curcuma longa sans curcuminoïde, dans les dermatoses inflammatoires
CN111166847B (zh) * 2019-12-23 2021-12-31 成都锦华药业有限责任公司 一种含姜黄的药物组合物及其片剂和制备方法
RU2760551C1 (ru) * 2020-06-17 2021-11-29 федеральное государственное бюджетное научное учреждение "Федеральный центр токсикологической, радиационной и биологической безопасности" (ФГБНУ "ФЦТРБ-ВНИВИ") Способ лечения радиационных поражений организма и способ получения биологического препарата для лечения радиационных поражений организма

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401777A (en) * 1991-11-14 1995-03-28 Steigerwald Arzneimittelwerk Gmbh Use of preparations of curcuma plants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996003999A1 (es) * 1994-08-03 1996-02-15 A.S.A.C. Pharmaceutical International, A.I.E. Procedimiento para la obtencion de extractos apolares y polares de curcuma y aplicaciones de los mismos
US5891924A (en) * 1996-09-26 1999-04-06 Research Development Foundation Curcumin (diferuloylmethane) inhibition of NFκB activation
US6019735A (en) * 1997-08-28 2000-02-01 Visco Technologies, Inc. Viscosity measuring apparatus and method of use
US20020164374A1 (en) * 1997-10-29 2002-11-07 John Jackson Polymeric systems for drug delivery and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401777A (en) * 1991-11-14 1995-03-28 Steigerwald Arzneimittelwerk Gmbh Use of preparations of curcuma plants

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HUEI-CHEN HUANG et al. Inhibitory effect of Curcumin, an anti-inflammatory agent, on vascular smooth cell proliferation. European Journal of Pharmacology, 1992. Vol. 221, paginas 381-384. *
MIQUEL, J. et al. Effects of Turmeric on blood and liver lipoperoxide levels of mice: Lack of toxicity. AGE, 1995; Vol. 18, No 4, paginas 171-174. *
SIMON, A. et al. Inhibitory effect of Curcuminoids on MCF-7 cell proliferation and structure-activity relationships. Cancer Letters, 1998. Vol. 129, No 1, paginas 111-116. *

Also Published As

Publication number Publication date
DE60043609D1 (de) 2010-02-11
ES2154615B1 (es) 2001-11-16
ES2157862B1 (es) 2002-03-01
ES2154610B1 (es) 2001-11-16
WO2001021185A1 (es) 2001-03-29
ES2154610A1 (es) 2001-04-01
ATE453398T1 (de) 2010-01-15
US6841177B1 (en) 2005-01-11
AU7525300A (en) 2001-04-24
CA2351482A1 (en) 2001-03-29
ES2154615A1 (es) 2001-04-01
EP1133992B1 (en) 2009-12-30
EP1133992A1 (en) 2001-09-19
JP2003509464A (ja) 2003-03-11

Similar Documents

Publication Publication Date Title
ES2154610A1 (es) Nuevas actividades farmacologicas de los extractos de curcuma longa.
TR200102308T2 (tr) Yüzey etkinliğine sahip yapay peptidler ve bunların yapay yüzey aktif maddelerin hazırlanmasında kullanımı
MX9704655A (es) Auxiliar de entrenamiento de esfinteres que crea un cambio de temperatura.
ATE229272T1 (de) Desinfizierende zusammensetzung auf basis von h2o2, säuren und metallionen
ATE163042T1 (de) Lactobazillusstämme menschlichen ursprungs, ihre zusammensetzung und deren verwendung
DE60142084D1 (de) Anwendung von glp-2 in verbindung mit einem anderen therapeutischen mittel in knochenkrankheiten
ES2175460T3 (es) Compuesto de lipoxinas y su utilizacion en el tratamiento de patologias con proliferacion celular.
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
HK1046912B (zh) 取代的皂苷酸基及它們的用途
DE69435307D1 (de) Bazillus Thuringiensis und dessen insektizide Proteine
ES2190246T3 (es) Nuevos compuestos de tiazolopirimidina.
ES2137372T3 (es) Solucion antifungica para las uñas.
ES2167401T3 (es) Uso de ascorbil-gamma-linolenato o un ascorbil-dihomo-gamma-linolenato para el tratamiento de asma, cancer, enfermedades cardiovasculares y anti-inflamatorias.
DE69906944D1 (de) 20-hete antagonisten und agonisten
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
MXPA03003774A (es) Derivados de acilo y sulfonilo de 2-(trans-1, 4-diaminociclohexil)-purinas 6,9-disubstituidas y sus uso como agentes antiproliferativos.
AU7538700A (en) 5-hydroxysapogenin derivatives with anti-dementia activity
ATE189261T1 (de) Bifunktionelle urokinasevarianten mit verbesserten fibrinolytischen eigenschaften und thrombinhemmender wirkung
ITBO970722A0 (it) Trattamento di reticolazione e sterilizzazione per la produzione di ma nufatti in polietilene ad elevate caratteristiche tribologiche, parti
TR199700435A2 (xx) Pestisit florolefin bile�imlerinin haz�rlanmas� i�in i�lem ve ara bile�imler.
GB9723824D0 (en) Cytostatic agents
AU2001293700A1 (en) Biochemical markers of the human endometrium
DE60141169D1 (de) Verwendung einer zusammensetzung mit n-acetylcystein zur konditionierung von stammzellen
AU132015S (en) Pants
DE59307222D1 (de) Zusammensetzung zur bekämpfung von dermatomykosen und deren erregern sowie von schweissbildung und körpergeruch

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20160120

Kind code of ref document: A1

Effective date: 20160120

FD2A Announcement of lapse in spain

Effective date: 20190612